SCHEMBL6301762

SCHEMBL6301762

CN1CCC2CCC=CC2=CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10434273 0.69 ALDH1A1 (0.35)
SCHEMBL6301634 0.68 KMT2A (0.30)
SCHEMBL6369317 0.68 KMT2A (0.30)
SCHEMBL6364355 0.66
SCHEMBL6301679 0.66
SCHEMBL761830 0.65
SCHEMBL7346464 0.64
SCHEMBL8305417 0.62
SCHEMBL9043133 0.59 MEN1 (0.31)
SCHEMBL18080895 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050267150-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C 2005-12-01 US disclosed
US-20050261495-A1 Lactam Compound AUDIA JAMES E 2005-11-24 US disclosed
US-20050192269-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C (US) 2005-09-01 US disclosed
US-20050192265-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C (US) 2005-09-01 US disclosed
US-6906056-B2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds ELAN PHARMACEUTICALS, INC. (US) 2005-06-14 US disclosed
US-20040248878-A1 Lactam compound KOENIG THOMAS MITCHELL (US) 2004-12-09 US disclosed
US-20040106598-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C (US) 2004-06-03 US disclosed
US-20040077627-A1 Lactam compound KOENIG THOMAS MITCHELL (US) 2004-04-22 US disclosed
EP-1353910-A2 LACTAM COMPOUND ELI LILLY AND COMPANY (US) 2003-10-22 EP disclosed
EP-1345955-A2 LACTAM DIPEPTIDE AND ITS USE IN INHIBITING BETA-AMYLOID PEPTIDE RELEASE ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
EP-1341531-A2 LACTAM COMPOUND TO INHIBIT BETA-AMYLOID PEPTIDE RELEASE OR SYNTHESIS ELI LILLY AND COMPANY (US) 2003-09-10 EP disclosed
US-6569851-B1 Treating Alzheimer's disease ELAN PHARMACEUTIALS, INC. 2003-05-27 US disclosed
WO-2002047671-A2 LACTAM COMPOUND TO INHIBIT BETA-AMYLOID PEPTIDE RELEASE OR SYNTHESIS ELI LILLY AND COMPANY (US) 2002-06-20 WO disclosed
WO-2002040508-A2 LACTAM DIPEPTIDE AND ITS USE IN INHIBITING BETA-AMYLOID PEPTIDE RELEASE ELI LILLY AND COMPANY (US) 2002-05-23 WO disclosed
WO-2002040451-A2 LACTAM COMPOUND ELI LILLY AND COMPANY (US) 2002-05-23 WO disclosed
EP-1089980-A1 COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS Elan Pharmaceuticals, Inc. (US) 2001-04-11 EP disclosed
WO-1999067221-A1 COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS ELAN PHARMACEUTICALS, INC. (US) 1999-12-29 WO disclosed